Abstract: FR-PO0273
Nurse-Led, Person-Centred Quality Improvement Increases Pneumococcal Vaccination Coverage in Patients with Advanced CKD: Experience from a Multicultural Low-Clearance Clinic in Qatar
Session Information
- CKD: Omics, Systemic Stressors, and Targeted Pharmacotherapy
October 23, 2026 | Location: Exhibit Hall A, Convention Center
Abstract Time: 10:00 AM - 12:00 PM
Category: CKD (Non-Dialysis)
- 2201 CKD (Non-Dialysis): Epidemiology, Risk Factors, and Prevention
Authors
- Ghonimi, Tarek Abdellatif, Hamad Medical Corporation, Doha, Qatar
- Singh, Poonam Ravinder, Hamad Medical Corporation, Doha, Qatar
- Aly, Sahar, Hamad Medical Corporation, Doha, Qatar
- Tolba, Hoda, Hamad Medical Corporation, Doha, Qatar
- Khater, Iman Ibrahim M. A., Hamad Medical Corporation, Doha, Qatar
- Hamad, Abdullah Ibrahim, Hamad Medical Corporation, Doha, Qatar
Background
Patients with advanced CKD face elevated risk from invasive pneumococcal disease, yet vaccination rates remain suboptimal. An audit at our Low Clearance Clinic (LCC), Fahad Bin Jassim Kidney Center, HMC, Qatar (July 2024) identified only 46% coverage. We aimed to reach ≥90% within three months using a nurse-led, person-centred QI intervention.
Methods
A prospective QI study using the Model for Improvement was conducted via three PDSA cycles (July–September 2024; n=48; median age 62 years, 58% male, multinational). The bundle included: (1) multilingual culturally adapted education addressing vaccine hesitancy; (2) barrier assessment interviews; (3) flexible scheduling; (4) transportation support; and (5) telephone/SMS reminders. Outcomes: vaccination coverage (primary), education compliance (process), patient satisfaction (balancing). Run charts with shift rules were applied.
Results
Coverage rose from 46% to 71% (July), 87% (August), and 94% (September 2024), exceeding the ≥90% target. A run chart shift (eight consecutive points above baseline median) confirmed non-random improvement from week 5. Education compliance reached 100%; patient satisfaction reached 100% with no adverse balancing effects. Two patients declined after repeated counselling. The protocol was embedded into LCC standard operating procedures by October 2024.
Conclusion
This pilot shows that a nurse-led, culturally competent QI bundle can rapidly close a major vaccination gap in a high-risk CKD population. Barrier identification, multilingual education, and logistical support were the key drivers. We plan to scale to all LCC patients with a standardised protocol and tracking dashboard (2025–2026), as a blueprint for broader HMC nephrology immunisation programmes.
Funding
- Government Support – Non-U.S.